Aptar Pharma says new eDevices will speed up regulatory approval
6 Minuten
Podcast
Podcaster
Beschreibung
vor 13 Jahren
Aptar Pharma says its new eDevices can help companies gain quicker
regulatory approval for their nasal drug products without having to
re-do clinical trials.
regulatory approval for their nasal drug products without having to
re-do clinical trials.
Weitere Episoden
3 Minuten
vor 11 Jahren
3 Minuten
vor 12 Jahren
5 Minuten
vor 12 Jahren
4 Minuten
vor 12 Jahren
7 Minuten
vor 12 Jahren
In Podcasts werben
Kommentare (0)